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Summanr Primary non-Hodgkin Iymphoma of the brain is rare, representing only 10/0 of all non-Hodgkin
lImphomas (NHLs). but its incidence has been increasing rapidly in south-east England since 1985. Among
17.322 cases of NHL registered during the 18 year period 1973-90. there were 210 cases of primary cerebral
NHL. of which 179 (860 o) were diagnosed in the last third of this period. 1985-90. This increase in cerebral
lymphoma is not adequately explained by improvements in the precision of diagnosis or by changes in disease
coding or cancer registration practice. While there has also been a rapid increase in Kaposi sarcoma. neither
immunosuppression acquired through HIV infection nor the overall trend in non-Hodgkin lImphoma can
satisfactonily explain the recent increase in cerebral lymphoma. which affects all ages and both sexes similarly.
Other possible causes for a true increase in cerebral lImphoma should be sought.
Primary non-Hodgkin lymphoma (NHL) of the brain is rare.
constituting around 1% of all NHL cases. The average
annual incidence rate for NHL at all sites combined ranges
between 9 and 12 per 100.000 per year in south-east England
(Thames Cancer Registry, 1993; Chamberlain et al.. 1993).
with age-standardised rates between 4.8 and 8.3 per 100,000.
The incidence of NHL is known to be increasing quite
rapidly in many populations, including south-east England
(Coleman et al.. 1993). and non-Hodgkin lymphoma presen-
ting as a primary cerebral tumour has become more common
in the USA (Eby et al., 1988). Further exploration of the
trends in NHL in south-east England revealed that in the 18
year period 1973-90. the incidence of primary cerebral NHL
increased more than 10-fold. much more rapidly than NHL
as a whole. This short report explores possible explanations.
Materials and methods
Thames Cancer Registry has been collecting population-
based data on the incidence of all malignant neoplasms in
south-east England. including the capital, London, since
1960. initially from the territory now covered by the South
Thames Regional Health Authority (RHA) and, since 1985,
from both North and South Thames RHAs. Methods have
been described previously (Thames Cancer Registry. 1992,
1993). The registry covers a population of 14 million, or a
quarter of the population of England and Wales. Exper-
ienced registry staff collect data actively by visiting over 260
hospitals and other health care units. Registrations are
systematically coded to the International Classification of
Diseases for Oncology (World Health Organization. 1976),
by entering the pathological and clinical description of the
tumour, abstracted from the medical record, into a computer
system which incorporates all ICD-O terms and synonyms.
The coding of difficult cases is discussed with the patient's
clinician or with a senior cancer histopathologist who acts as
the Registry's advisor. For this study, cases of primary cere-
bral lymphoma were defined by ICD-O topography code 191
(brain) and a morphology code in the range 9590-9642
(lymphomas and reticulosarcomas). The current version of
ICD-O was issued in 1976. and does not include the degree
of malignancy of lymphoma introduced in the 1982 Working
Formulation (Percy et al.. 1984). Changes in the proportion
of high-grade lymphomas cannot therefore be assessed from
routinely collected registry data, but since 1985 data on T-
and B-cell subtypes of lymphoma and HIV status at diag-
nosis of NHL have been routinely collected if available in the
medical record. The quality of data collected routinely for
cancer registration is dependent on both the quality and the
completeness of information included in the clinical records
of cancer patients (Gulliford et al.. 1993: Vickers & Pollock,
1993).
The number of cases and the mean annual incidence rate
per 100.000 were calculated by age and sex for each of six
consecutive 3 year periods between 1973 and 1990. Incidence
rates for single years were unstable: even in such a large
population. fewer than 20 cases of primary cerebral NHL
were recorded in most of the years covered by the study; 3
year periods were the shortest for which rates were ade-
quately stable. Trends in the crude rate were tested with the
extended Mantel-Haenszel chi square. Rates were also age
standardised with world standard weights (Smith, 1987). and
incidence trends were modelled with Poisson regression (Bres-
low & Day, 1987). using stepwise inclusion of parameters to
test the effect of calendar period (six periods), sex, age at
diagnosis (0-19, 20-39, 40-59 and 60 years and over) and
single year of birth on the trend.
Results
Among 17.322 cases of NHL diagnosed at all ages during the
period 1973-90, 210 patients (1.2%) had primary cerebral
NHL, of whom 179 (85%) were diagnosed in the period
1985-90. All 210 cases had a histopathological diagnosis.
Four-fifths (81%. 14,038 cases) of the lymphomas were
classified as diffuse NHL or NHL not otherwise specified.
1.387 (8%) as T-cell or B-cell lymphoma, 1,008 (6%) as
reticulosarcoma. 845 (5%) as nodular or follicular lym-
phoma. and 44 (0.3%) as Burkitt's lymphoma.
Age-standardised incidence rates of all types of NHL com-
bined rose steadily from 4.9 to 9.1 per 100,000 during
1973-90. This trend is roughly linear with time (see Figure
1), and is largely due to the weight of incidence at ages 60
and over, which represents two-thirds of the cases. Incidence
at ages under 60 has been increasing slightly more rapidly
than for older persons since 1985 (data not shown). Over the
period 1973-90. there were 225 (1.3%) cases of NHL with
an unspecified localisation. but there was no trend in this
percentage in any age group.
For primary cerebral lymphoma. the crude incidence in-
creased more than 10-fold during 1973-90. from 0.025 to
0.276 per 100,000. The male-female ratio was stable at
about 1.8 throughout this period. and data for both sexes are
combined. Incidence since 1985 was similar in North and
South Thames, and data for these regions are also combined.
The age-standardised rate increased by 21% in the 12 years
1973-84. from 0.024 to 0.029 per 100,000, but it rose by a
further 9-fold (age-adjusted rate ratio 9.0, 95% CI 4.0-20.5)
to 0.206 in the 6 years 1985-90, while non-Hodgkin lym-
phoma at other sites and for all sites combined increased by
only 1.3-fold during 1985-90 (see Table I). In contrast to the
age-specific trends for all types of NHL combined. the trend
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Figure I Trends in non-Hodgkin lymphoma and Kaposi sar-
coma. south-east England. 1973-90: age-adjusted incidence rates
per 100.000. OAII NHLs; X. digestive tract. *. oropharynx; A.
Kaposi sarcoma: 0. brain.
for cerebral lymphoma was similar at all ages. A simple
model including only calendar period fits the data well, and
although the overall fit is significantly improved by inclusion
of age and sex in the model. estimates of the rate ratio were
similar (data not shown).
During the period 1985-90. information on HIV status
was available for only 39 (22%) of the patients with cerebral
lymphoma. of whom eight (210%) were seropositive; these
proportions did not vary markedly during the period.
Discus
A rapid increase in primary cerebral lymphoma in south-east
England has affected all ages and both sexes since the early
1980s. Possible explanations for this increase include better
diagnosis and shifts in classification. Computerised axial
tomography has been available since 1978 and magnetic
resonance imaging since 1980: both greatly improved the
diagnosis of cerebral tumours. but cerebral NHL did not
increase until 1985. The rapid increase in cerebral lymphoma
cannot be due to diagnostic shift from microglioma (Henry et
al.. 1974). since in the period 1980-84 fewer than five micro-
gliomas were registered each year. The term reticulosarcoma
has been progressively replaced in pathology reports by B-
and T-cell lymphoma. but these occur in both brain and
other sites of lymphoma. while the increase is only seen for
cerebral lymphoma.
The overall incidence of NHL has certainly increased. as
has been noted previously (Coleman et al.. 1993). but the
9-fold increase in primary cerebral lymphoma between
1982-84 and 1988-90 is too recent and too large to be
explained convincingly as just part of the overall trend in
NHL. and the trend in other extranodal sites of NHL over
the 18 year period is quite unlike that for cerebral NHL
(Figure 1). There has been no increase in the incidence of
cerebral glioma, which, like NHL. is generally diagnosed by
brain biopsy. so improved diagnostic techniques are also an
unlikely explanation for the sudden increase in cerebral
NHL.
Possible explanations for a true increase in cerebral NHL
would include an increase in high-grade malignancy (Boring
et al.. 1985). due to immunodeficiency acquired either from
HIV infection or following organ transplantation. These
points cannot be addressed directly with routinely collected
cancer registry data. but indirect inference is helpful. The
incidence of Kaposi sarcoma (KS). a tumour closely linked
with AIDS (Reynolds et al.. 1993), increased by 15-fold in
south-east England between 1982-84 and 1988-90 (Thames
Cancer Registry. unpublished data) for all ages combined.
and by 60-fold among 20- to 39-year-olds; 60% of all KS
cases now arise in this age group. The increase in cerebral
NHL reported here is independent of age and sex. not at all
what would be expected if the increase were related to HIV
infection, and quite unlike the age-specific trend seen for KS
both here and in the USA (Eby et al.. 1988). The increase in
KS also began 5 years earlier and has been even more rapid
than the increase in cerebral NHL. From the few cases of
cerebral lymphoma in this series for which the HIV status at
diagnosis was known, there was no change in the proportion
of seropositivity between 1985 and 1990. The risk of non-
Hodgkin lymphoma following renal or cardiac transplanta-
tion is certainly high. particularly in the first year after
transplantation. but there is a marked preference for these
lymphomas to arise in kidney or heart respectively (Opelz &
Henderson. 1993). and while transplant recipients are gener-
ally younger than 60 the increase in incidence of cerebral
NHL also affects older persons. both in our data and in the
USA (Eby et al.. 1988).
In conclusion. we have observed a striking increase in the
incidence of primary non-Hodgkin lymphoma of the brain.
The probability of a patient with NHL at age 20 or more
presenting with a cerebral localisation is some nine times
higher than it was only 10 years ago. This increase is not due
to change in registration practice or coding schemes, nor to
the introduction of modern diagnostic techniques. It does not
appear to be related to age. sex. HIV seropositivity or the
overall trend in NHL. The data are not adequate to evaluate
other possible causes for the increase. The second edition of
ICD-O (World Health Organization. 1990). incorporating the
Working Formulation for the classification of the lym-
phomas. should enable the assessment of trends in high-grade
malignancy in future. Meanwhile, these routinely collected
data from a cancer registry help to identify a rapid increase
in primary cerebral lymphoma. but not of other extranodal
sites of NHL or of other brain tumours. It would be valuable
to check this observation in other populations.
Table I Non-Hodgkin lymphoma incidence trends by site, south-east England. 1982-90: no. ofcases and rate per 100.000 bv age. with
age-standardised rate (ASR) and age-adjusted rate ratio (9500 confidence interval)
All sites Brain Digestive tract
1982-84 1988-90 1982-84 1988-90 1982-84 1988-90
Age group Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
0-19 45 0.87 141 1.34 0 0.0 1 0.009 2 0.039 6 0.057
20-39 183 3.26 527 4.17 2 0.036 17 0.134 9 0.160 13 0.103
40-59 512 12.69 1348 13.74 2 0.068 48 0.489 36 0.822 85 0.866
60+ 1374 30.97 3555 40.89 2 0.045 49 0.564 91 2.052 244 2.807
Total 2114 10.78 5571 13.36 6 0.036 115 0.276 138 0.704 348 0.835
ASR 7.12 9.08 0.029 0.206 0.459 0.542
Rate ratio 1.3 9.0 1.3
(950 CI) (1.2-1.4) (4.0-20.5) (1.1-1.6)
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